| Closed |
S0325 |
Phase IIb Imatinib or Dasatinib for Untreated Chronic CML |
8/15/2004 |
2/28/2009 |
100% |
|
Published
|
| Closed |
SWOG-9460 |
Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma |
6/1/1996 |
10/15/1999 |
34% |
|
Published
|
| Closed |
SWOG-8737 |
Phase III AZQ 24-hour Infusion versus BCNU for Adult High Grade Gliomas |
8/15/1988 |
5/15/1991 |
100% |
|
Published
|
| Closed |
S0819 |
Phase III Carbo/Taxol/Bevacizumab +/- Cetuximab in Advanced NSCLC |
7/15/2009 |
5/1/2015 |
78% |
|
Published
|
| Closed |
SWOG-9313 |
Phase III Comparison of Adjuvant Chemotherapy with High-Dose Cyclophosphamide plus Doxorubicin (AC) versus Sequential Doxorubicin followed by Cyclophosphamide (A’C) in High-Risk Breast Cancer… |
3/15/1994 |
5/1/1997 |
98% |
|
Published
|
| Closed |
S0232 |
Phase III Double-Blinded Placebo Controlled Previously Untreated Multiple Myeloma |
11/1/2004 |
5/11/2007 |
40% |
|
Published
|
| Closed |
S0777 |
Phase III LD vs. VLD for Induction, followed by Transplant in Multiple Myeloma |
4/1/2008 |
2/1/2012 |
100% |
|
Published
|
| Closed |
S0521 |
Phase III Maint. vs. Obs. for Low and Intermediate Risk APL |
6/1/2007 |
|
19% |
|
Published
|
| Closed |
S0106 |
Phase III Starndard + Mylotarg vs. Standard + Daunomycin/Ara-C for AML Under Age 61 |
5/15/2004 |
8/20/2009 |
93% |
|
Published
|
| Closed |
SWOG-8833 |
Phase ll Investigation of Chlorambucil and Fludarabine Monophosphate in Relapsed or Refractory Chronic Lymphocytic Leukemia |
5/15/1989 |
4/15/1991 |
88% |
|
Published
|
| Closed |
SWOG-8734 |
Phase ll Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Stomach |
3/1/1988 |
1/1/1990 |
86% |
|
Published
|
| Closed |
SWOG-8814 |
Phase lll Comparison of Adjuvant Chemoendocrine Therapy with CAF and Concurrent or Delayed Tamoxifen to Tamoxifen Alone in Postmenopausal Patients with Involved Axillary Lymph Nodes and Positive… |
5/15/1989 |
8/1/1995 |
100% |
|
Published
|
| Closed |
SWOG-9051 |
Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II |
4/15/1992 |
4/1/1995 |
100% |
|
Published
|
| Closed |
SWOG-9009 |
Pilot Study for Analysis of Lymphocyte Subsets and Natural Killer Activity after Treatment with Levamisole |
12/15/1990 |
8/7/1992 |
95% |
|
Published
|
| Closed |
SWOG-8572 |
Pilot Study of Continuous Low-Dose 5-Fluorouracil Infusion and Radiation Therapy as Adjuvant Treatment for Duke's-C Colon and Rectal Cancer |
5/9/1986 |
6/15/1991 |
64% |
|
Published
|
| Closed |
SWOG-8750 |
Pilot Study to Examine Cytogenetic Abnormalities in Patients with Acute Leukemia, Ancillary |
4/15/1987 |
10/15/1991 |
|
|
Published
|
| Closed |
SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021) |
Pos Op RT Single Brain Met |
7/15/1991 |
12/1/1994 |
25% |
|
Published
|
| Closed |
SWOG-9239 |
Post-Organ Transplant Lymphoproliferation Treatment |
4/15/1995 |
8/15/2000 |
40% |
|
Published
|
| Closed |
S0000A |
PREADVISE |
5/17/2002 |
9/30/2009 |
72% |
|
Published
|
| Closed |
SWOG-8006 |
Preoperative Reductive Chemotherapy for Stage III or IV Operable Epidermoid Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx or Larynx |
7/14/1980 |
2/20/1985 |
|
|
Published
|
